Fund+

Investor type

PE / VC

Founded

2015

AUM

$200 M

Location

Belgium

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series B, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium. We want to create sustainable shareholders value, contribute to the development of a leadership position in the Life Sciences sector and generate a tangible, beneficial societal impact.

Industry

Healthcare Services Life Sciences HealthTech Biotechnology Medical Devices Pharmaceuticals MedTech

Region of investment

Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
eKbk42gOQ0MF7lGq eKbk42gOQ0MF7lGq
eKbk42gOQ0MF7lGq
avatar
eKbk42gOQ0MF7lGq eKbk42gOQ0MF7lGq
eKbk42gOQ0MF7lGq
avatar
eKbk42gOQ0MF7lGq eKbk42gOQ0MF7lGq
eKbk42gOQ0MF7lGq
avatar
eKbk42gOQ0MF7lGq eKbk42gOQ0MF7lGq
eKbk42gOQ0MF7lGq
avatar
eKbk42gOQ0MF7lGq eKbk42gOQ0MF7lGq
eKbk42gOQ0MF7lGq
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Fund+

Fund+ is located in Belgium.
Fund+ was founded in 2015.
Fund+ invests in companies and startups in Healthcare Services, Life Sciences, HealthTech, Biotechnology, Medical Devices, Pharmaceuticals, MedTech.
Fund+ invests in companies and startups in Europe.
Fund+ invests in companies and startups at Seed, Series B, Series A.
Fund+ usually invests $10-50 m on average.
Fund+ has around $200m assets under management.